The Role of Lidocaine Spray in Reducing Pain During Intrauterine Device Application

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07155785

Acronym

Lidocaine IUD

Enrollment

Registered

2025-09-04

Start date

2022-07-01

Completion date

2023-05-25

Last updated

2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Device Migration, Pain

Keywords

intrauterine device, pain

Brief summary

Investigators aimed to investigate the effectiveness of the use of local lidocaine spray application to make routine intrauterine intrauterine device application more painless.

Detailed description

As a standard, no anaesthesia is applied to the patient during intrauterine device application in outpatient clinic conditions. Patients can usually tolerate the procedure even if there is minimal pain and discomfort. In patients with low pain tolerance, the procedure can be terminated before the application can be performed and the application can be repeated under local or general anaesthesia. Local anaesthetic sprays are routinely and comfortably used in episiotomy repair, upper gastrointestinal tract endoscopy and intraoral procedures. In our study, investigators aimed to demonstrate the efficacy of local spray anaesthesia without side effects for the relief of pain that occurs in some patients during intrauterine device application by comparing it with placebo.

Interventions

DRUGLidocain spray

Lidocaine spray as a local anaesthetic agent was applied to the cervix before intrauterine device application.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Investigator)

Masking description

off labeled and hidden bottle usage during spray apply

Intervention model description

double blind randomized controlled study

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* 18-45 years old patient who comes to have an intrauterine device inserted voluntarily * The patient who gave consent to participate in the study

Exclusion criteria

* Patients who cannot have an intrauterine device because of fibroids or cervical stenosis * Patient who did not want to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Pain component	1 hour	Reduction of the pain felt during application of the intrauterine device

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026